Organovo Receives Strong Customer Response for ExVive Human Kidney Tissue Launch
November 01, 2016 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Nov. 01, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Announces Release Date for Fiscal Second-Quarter 2017 Financial Results
October 24, 2016 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Oct. 24, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using...
Organovo Prices Approximately $25 Million Public Offering of Common Stock
October 20, 2016 09:11 ET
|
Organovo, Inc.
SAN DIEGO, Oct. 20, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Announces Proposed Public Offering of Common Stock
October 19, 2016 16:07 ET
|
Organovo, Inc.
SAN DIEGO, Oct. 19, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Announces Select Preliminary Second-Quarter 2017 Results; Company Updates Full-Year Fiscal 2017 Outlook
October 11, 2016 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Oct. 11, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Introduces 3D Bioprinted Human Liver as Leading Therapeutic Tissue in Preclinical Development
October 05, 2016 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Oct. 05, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo and Collaborators Publish Data in Toxicological Sciences Demonstrating Power of 3D Bioprinted Human Liver Tissues in Modeling Drug-Induced Liver Injury Leading to Fibrosis
September 13, 2016 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Sept. 13, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Announces Initiation of Commercial Contracting for ExVive Human Kidney Tissue
September 07, 2016 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Appoints Two New Members to Board of Directors
August 18, 2016 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Aug. 18, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Announces Fiscal First-Quarter 2017 Results; Company Affirms Full-Year Fiscal 2017 and Long-Range Outlook
August 04, 2016 16:10 ET
|
Organovo, Inc.
SAN DIEGO, Aug. 04, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NYSE MKT:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...